Julia Mhlaba Riley, MD, FAAD
SESSIONS
U018 Innovative and Advanced Management of Biologics and Small Molecule Inhibitors in Hidradenitis Suppurativa and Beyond
Mar 27, 2026
•
3:30 PM - 4:30 PM
•
Bluebird 3E
U071 Advancing HS Diagnosis with Artificial Intelligence: A Multi-Phased Collaborative Approach
Mar 29, 2026
•
8:00 AM - 9:00 AM
•
Mile High 2A
DISCLOSURES
AbbVie – Investigator(Fees); Incyte Corporation – Investigator(Fees); MoonLake Immunotherapeutics – Investigator(Fees); Novartis – Investigator(Fees); UCB – Advisory Board(Fees);